Your browser doesn't support javascript.
loading
Evaluation of heteroscorpionate ligands as scaffolds for the generation of Ruthenium(II) metallodrugs in breast cancer therapy.
Domínguez-Jurado, Elena; Ripoll, Consuelo; Lara-Sánchez, Agustín; Ocaña, Alberto; Vitórica-Yrezábal, Iñigo J; Bravo, Iván; Alonso-Moreno, Carlos.
Afiliación
  • Domínguez-Jurado E; Universidad de Castilla-La Mancha, Unidad nanoDrug, Facultad de Farmacia de Albacete, 02008 Albacete, Spain; Universidad de Castilla-La Mancha, Departamento de Química Inorgánica, Orgánica y Bioquímica, Facultad de Ciencias y Tecnologías Químicas-Centro de Innovación en Química Avanzada (ORFEO-CINQA
  • Ripoll C; Universidad de Castilla-La Mancha, Unidad nanoDrug, Facultad de Farmacia de Albacete, 02008 Albacete, Spain; Universidad de Castilla-La Mancha, Departamento de Química Física. Facultad de Farmacia de Albacete, Albacete 02071, Spain.
  • Lara-Sánchez A; Universidad de Castilla-La Mancha, Departamento de Química Inorgánica, Orgánica y Bioquímica, Facultad de Ciencias y Tecnologías Químicas-Centro de Innovación en Química Avanzada (ORFEO-CINQA), Ciudad Real 13071, Spain.
  • Ocaña A; Experimental Therapeutics Unit, Hospital clínico San Carlos, IdISSC and CIBERONC, Madrid, Spain.
  • Vitórica-Yrezábal IJ; Departamento de Química Inorgánica, Facultad de Ciencias, Universidad de Granada, Avda de Fuentenueva. s/n, 18071 Granada, Spain.
  • Bravo I; Universidad de Castilla-La Mancha, Unidad nanoDrug, Facultad de Farmacia de Albacete, 02008 Albacete, Spain; Universidad de Castilla-La Mancha, Departamento de Química Física. Facultad de Farmacia de Albacete, Albacete 02071, Spain.
  • Alonso-Moreno C; Universidad de Castilla-La Mancha, Unidad nanoDrug, Facultad de Farmacia de Albacete, 02008 Albacete, Spain; Universidad de Castilla-La Mancha, Departamento de Química Inorgánica, Orgánica y Bioquímica, Facultad de Ciencias y Tecnologías Químicas-Centro de Innovación en Química Avanzada (ORFEO-CINQA
J Inorg Biochem ; 253: 112486, 2024 04.
Article en En | MEDLINE | ID: mdl-38266323
ABSTRACT
The modular synthesis of the heteroscorpionate core is explored as a tool for the rapid development of ruthenium-based therapeutic agents. Starting with a series of structurally diverse alcohol-NN ligands, a family of heteroscorpionate-based ruthenium derivatives was synthesized, characterized, and evaluated as an alternative to platinum therapy for breast cancer therapy. In vitro, the antitumoral activity of the novel derivatives was assessed in a series of breast cancer cell lines using UNICAM-1 and cisplatin as metallodrug control. Through this approach, a bimetallic heteroscorpionate-based metallodrug (RUSCO-2) was identified as the lead compound of the series with an IC50 value range as low as 3-5 µM. Notably, RUSCO-2 was found to be highly cytotoxic in TNBC cell lines, suggesting a mode of action independent of the receptor status of the cells. As a proof of concept and taking advantage of the luminescent properties of one of the complexes obtained, uptake was monitored in human breast cancer MCF7 cell lines by fluorescence lifetime imaging microscopy (FLIM) to reveal that the compound is evenly distributed in the cytoplasm and that the incorporation of the heteroscorpionate ligand protects it from aqueous processes, conversion in another entity, or the loss of the chloride group. Finally, ROS studies were conducted, lipophilicity was estimated, the chloride/water exchange was studied, and stability studies in simulated biological media were carried out to propose structure-activity relationships.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rutenio / Neoplasias de la Mama / Complejos de Coordinación / Antineoplásicos Límite: Female / Humans Idioma: En Revista: J Inorg Biochem Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rutenio / Neoplasias de la Mama / Complejos de Coordinación / Antineoplásicos Límite: Female / Humans Idioma: En Revista: J Inorg Biochem Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos